Form 4: Rezolute CMO Sells Shares for Tax Obligations

Rezolute's Chief Medical Officer, Brian Kenneth Roberts, disposed of 11,439 common shares to cover tax withholding obligations related to Restricted Stock Unit vesting.

Summary

• Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc. (RZLT), reported a disposition of common shares.
• The transaction involved 11,439 common shares on March 2, 2026.
• The shares were sold at a weighted average price of $2.99 per share, with individual sales ranging from $2.98 to $3.07.
• This disposition was a 'sell to cover' transaction to satisfy tax withholding obligations upon the vesting and settlement of Restricted Stock Units (RSUs).
• The transaction was mandated by the Issuer and was not a discretionary sale by Mr. Roberts.
• Following the transaction, Mr. Roberts directly owns 296,913 common shares and indirectly owns 15,500 common shares held in an IRA.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event, as the share disposition was non-discretionary and solely for tax purposes related to RSU vesting, which itself is a positive for the executive.

Positives

• The disposition was not a discretionary sale, but rather a mandatory 'sell to cover' transaction to satisfy tax obligations arising from the vesting of Restricted Stock Units (RSUs), indicating RSU vesting occurred.

Negatives

• Chief Medical Officer Brian Kenneth Roberts disposed of 11,439 common shares.

Future Outlook

NA

Management Comments

• The disposition represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ('RSUs').
• The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary transaction by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are common for executives receiving equity compensation and are generally not indicative of a change in management's sentiment towards the company's prospects, unlike discretionary sales.

Stakeholder Impact

• Shareholders: Minor dilution from the sale, but the non-discretionary nature limits negative sentiment.
• Employees: RSU vesting is a standard part of executive compensation.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary 'sell to cover' transaction by a Chief Medical Officer to satisfy tax obligations upon RSU vesting. It does not reflect a change in the executive's investment sentiment or provide new material information about the company's operational or financial performance, thus warranting a 'hold' recommendation based solely on this filing.

Keywords

Rezolute, RZLT, Form 4, Insider Trading, Stock Sale, Restricted Stock Units, RSU, Tax Withholding, Chief Medical Officer, Brian Kenneth Roberts